Pediatric Cancer Treatment Drugs Market Trends

  • Report ID: 3909
  • Published Date: Aug 21, 2024
  • Report Format: PDF, PPT

Pediatric Cancer Treatment Drugs Market Trends

Growth Drivers

  • Increasing Occurrence of Cancer Among Children
  • Rising Prevalence of Childhood Obesity Worldwide

Challenges

  • High Cost of Pediatric Cancer Treatment
  • Pediatric Cancer Treatment Drugs Market

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3909
  • Published Date: Aug 21, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Pediatric Cancer Treatment Drugs Market size is poised to witness lucrative growth rate during the forecast period i.e., between 2024-2036.

The market growth is driven by increasing occurrence of cancer among children, and rising prevalence of childhood obesity worldwide.

Asia Pacific industry is poised to dominate majority revenue share by 2036, ascribed to increasing government investments to enhance the medical infrastructure, and rising awareness about different treatment options in pediatric oncology.

The major players in the market are Bristol Myers Squibb Company, Epizyme, Inc., Eisai Co., Ltd., Recordati Rare Diseases Inc., Merck & Co., Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample